Hydrolysis ofcis- andtrans-Epoxyeicosatrienoic Acids by Rat Red Blood Cells
- 29 April 2008
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 326 (1), 330-337
- https://doi.org/10.1124/jpet.107.134858
Abstract
Erythrocytes serve as reservoirs for cis- and trans-epoxyeicosatrienoic acids (EETs). Incubation of rat red blood cells (RBCs) with cis- and trans-EETs produces threo- and erythro-dihydroxyeicosatrienoic acids, respectively. The Vmax of EET hydrolysis by rat intact RBCs (2.35 ± 0.24 pmol/min/108 RBCs for 14,15-trans-EET) decreased by approximately 2 to 3-fold sequentially from 14,15-, 11,12- to 8,9-EETs for both cis- and trans-isomers. The Vmax of trans-EET hydrolysis by RBCs is approximately 2 to 3 times that of the corresponding cis-EETs. Incubation of EETs with recombinant murine soluble epoxide hydrolase (sEH) yielded the same geometric and regio preferences of EET hydrolysis as with rat intact RBCs. The principal epoxide hydrolase activity for EET hydrolysis (approximately 90%) is present in the erythrocyte cytosol. Western blots of sEH suggested a concentration of sEH protein to be approximately 2 μg/mg protein or 0.4 μg/109 RBCs. The apparent Km values of EETs were between 1 and 2 μM, close to the Km for purified sEH as reported. Erythrocyte hydration of cis- and trans-EETs was blocked by sEH inhibitors, 1,3-dicyclohexylurea and 4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid. Erythrocyte sEH activity was inhibited more than 80% by 0.2% bovine serum albumin in the buffer. Preferred hydrolysis of 14,15-EETs and trans-epoxides characterizes sEH activity in RBCs that regulates the hydrolysis and release of cis- and trans-EETs in the circulation. Inhibition of sEH has produced antihypertensive and antiinflammatory effects. Because plasma trans-EETs would increase more than cis-EETs with sEH inhibition, the potential roles of trans-EETs and erythrocyte sEH in terms of circulatory regulation deserve attention.Keywords
This publication has 44 references indexed in Scilit:
- Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acidsBritish Journal of Pharmacology, 2007
- Orally Bioavailable Potent Soluble Epoxide Hydrolase InhibitorsJournal of Medicinal Chemistry, 2007
- Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivoProceedings of the National Academy of Sciences of the United States of America, 2007
- Soluble Epoxide Hydrolase: A Novel Therapeutic Target in StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)Prostaglandins & Other Lipid Mediators, 2007
- Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile FunctionCirculation Research, 2006
- Epoxyeicosatrienoic acids, cell signaling and angiogenesisProstaglandins & Other Lipid Mediators, 2006
- Vascular localization of soluble epoxide hydrolase in the human kidneyAmerican Journal of Physiology-Renal Physiology, 2004
- Arachidonic acid epoxygenase: Structural characterization and quantification of epoxyeicosatrienoates in plasmaBiochemical and Biophysical Research Communications, 1992
- Rat and human liver cytosolic epoxide hydrolases: evidence for multiple forms at level of protein and mRNA.Environmental Health Perspectives, 1990